Skip to content

Prospective cohort study on the incidence of SARS-CoV-2-infections (COVID-19) in professional orchestra musicians and choir singers

Prospective cohort study on the incidence of SARS-CoV-2-infections (COVID-19) in professional orchestra musicians and choir singers - ProMusik

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023385
Enrollment
2500
Registered
2020-11-06
Start date
2020-10-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: professional orchestra musicians exposed to aerosole production during regular orchestra play. Participants report test results/diagnoses received independent of the study. Group 2: professio

Sponsors

Charité Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All participants: - Male or female or diverse - At least 18 years old - Online consent is available Orchestra musician: - Member of a professional concert or opera orchestra Choir singer: - Member of a professional concert or opera choir control person: - non-musician of the same participating institution as the exposed persons (orchestra musicians and choristers) who are not exposed in the room during the rehearsals of the orchestra musicians and choristers and the concert.

Exclusion criteria

Exclusion criteria: All participants: - Current existence of a known infection with SARS-CoV-2 - Participants are dependent on the Institute of Social Medicine, Epidemiology and Health Economics or its staff Orchestral musician: - Musicians in pure string orchestras - Academics (members of an orchestra or choir academy) or freelancers who help out on a project basis but are not permanent members of the ensemble Choir singers: - Academics (members of an orchestra or choir academy) or freelancers who help out on a project basis but are not permanent members of the ensemble

Design outcomes

Primary

MeasureTime frame
Incidence of a SARS-CoV-2-infection

Secondary

MeasureTime frame
Occurrence of flu, influenza or upper respiratory tract infection, number of sick days

Countries

Germany

Contacts

Public ContactAnne Berghöfer

Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin

anne.berghoefer@charite.de+49 30 450 529034

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026